Thor Medical

Abdera Therapeutics Inc.’s approach for breaking into what it estimates is a $30bn market for radiopharmaceuticals centers around developing antibodies specifically designed to carry radioisotopes to

Midatech Pharma PLC ’s hopes of survival have been badly damaged by its own shareholders who have voted against the UK firm's proposed merger with Bioasis Technologies, Inc. . With cash reserves rapi

It seemed that troubled Nordic Nanovector ASA had secured its future through a merger with APIM Therapeutics AS but those hopes have been blown away after shareholders voted against a tie-up with

Having weighed up 25 possible M&A opportunities, troubled Nordic Nanovector ASA has been explaining why it decided to plump for a merger with fellow Norway-headquartered biotech APIM Therapeutics A